quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:23:38·45d
INSIDERFiling
Cencora Inc. logo

Director Tyler Lauren M was granted 641 shares, increasing direct ownership by 21% to 3,710 units (SEC Form 4)

COR· Cencora Inc.
Health Care
Original source

Companies

  • COR
    Cencora Inc.
    Health Care

Recent analyst ratings

  • Jan 29UpdateMorgan Stanley$400.00
  • Jan 22UpdateJefferies$440.00
  • Dec 9UpdateBarclays$400.00
  • Jun 3UpdateWells Fargo$337.00
  • Dec 4UpdateMizuho$280.00
  • Sep 18UpdateBofA Securities$245.00

Related

  • INSIDER21d
    SEC Form 4 filed by Krikorian Lazarus
  • PR22d
    Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Cencora Inc.
  • SEC31d
    Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR31d
    Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business
  • SEC37d
    Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR37d
    Cencora Announces Financial Leadership Transition
  • INSIDER41d
    Executive Vice President Battaglia Silvana converted options into 8,415 shares and covered exercise/tax liability with 3,673 shares, increasing direct ownership by 25% to 23,566 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022